CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 63 filers reported holding CTI BIOPHARMA CORP in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $80,000 | – | 235,048 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EAGLE ASSET MANAGEMENT INC | 15,707,022 | $38,010,000 | 0.11% |
| First Heartland Consultants, Inc. | 74,624 | $181,000 | 0.08% |
| WASHINGTON TRUST Co | 410,616 | $994,000 | 0.07% |
| Geduld E E | 40,000 | $97,000 | 0.07% |
| FIRST NEW YORK SECURITIES LLC /NY | 30,562 | $73,960,000 | 0.05% |
| Crosspoint Capital Strategies, LLC | 25,000 | $61,000 | 0.04% |
| JANE STREET GROUP, LLC | 1,434,975 | $3,473,000 | 0.04% |
| MAGEE THOMSON INVESTMENT PARTNERS LLC | 21,479 | $51,000 | 0.01% |
| TIAA CREF TRUST CO FSB/MO | 296,322 | $717,000 | 0.01% |
| Investors Capital Advisory Services | 16,950 | $41,000 | 0.01% |